Pfizer Inc. [PFE] took an upward turn with a change of -0.14%, trading at the price of $36.41 during the trading session on Thursday. The price movement in correlation with percentage of the mentioned increase can allow a valuable insight to investors. During the last trading session 7.32 million shares changed hands being bought and sold, while Pfizer Inc. shares have an average trading volume of 23.92M shares for that time period. PFE monthly volatility recorded 1.45%, in the meanwhile having share price volatility for the week set at 1.15%. PS value for PFE stocks is 3.78 with PB recorded at 3.40.
Pfizer Inc. [NYSE:PFE]: Analyst Rating and Earnings
Its stock price has been found in the range of 33.97 to 46.47. This is compared to its latest closing price of $36.46.
Pay attention for this company’s financial results, of which the next release is scheduled to happen on Tue 29 Oct (In 11 Days).
Fundamental Analysis of Pfizer Inc. [PFE]
Now let’s turn to look at profitability: with a current Operating Margin for Pfizer Inc. [PFE] sitting at +28.50 and its Gross Margin at +70.16, this company’s Net Margin is now 23.60%. These measurements indicate that Pfizer Inc. [PFE] is generating considerably more profit, after expenses are accounted for, compared to its market peers.
This company’s Return on Total Capital is 13.86, and its Return on Invested Capital has reached 10.20%. Its Return on Equity is 16.54, and its Return on Assets is 6.73. These metrics all suggest that Pfizer Inc. is doing well at using the money it earns to generate returns.
Turning to investigate this organization’s capital structure, Pfizer Inc. [PFE] has generated a Total Debt to Total Equity ratio of 65.83. Similarly, its Total Debt to Total Capital is 39.70, while its Total Debt to Total Assets stands at 26.18. Looking toward the future, this publicly-traded company’s Long-Term Debt to
What about valuation? This company’s Enterprise Value to EBITDA is 10.27 and its Total Debt to EBITDA Value is 1.93. The Enterprise Value to Sales for this firm is now 4.15, and its Total Debt to Enterprise Value stands at 0.15. Pfizer Inc. [PFE] has a Price to Book Ratio of 3.94, a Price to Cash Flow Ratio of 16.48 and P/E Ratio of 16.63. These metrics all suggest that Pfizer Inc. is more likely to generate a positive ROI.
Shifting the focus to workforce efficiency, Pfizer Inc. [PFE] earns $580,595 for each employee under its payroll. Similarly, this company’s Receivables Turnover is 6.60 and its Total Asset Turnover is 0.32. This publicly-traded organization’s liquidity data is also interesting: its Quick Ratio is 1.33 and its Current Ratio is 1.57. This company, considering these metrics, has a healthy ratio between its short-term liquid assets and its short-term liabilities, making it a less risky investment.
Pfizer Inc. [PFE] has 5.56B shares outstanding, amounting to a total market cap of $202.79B. Its stock price has been found in the range of 33.97 to 46.47. At its current price, it has moved down by -21.65% from its 52-week high, and it has moved up 7.18% from its 52-week low.
This stock’s Beta value is currently 0.65, which indicates that it is 1.15% more volatile that the wider market. This stock’s Relative Strength Index (RSI) is at 56.54. This RSI score is good, suggesting this stock is neither overbought or oversold.
Conclusion: Is Pfizer Inc. [PFE] a Reliable Buy?
Shares of Pfizer Inc. [PFE], overall, appear to be a solid investment option, with Wall Street analysts expecting its price to rise considerably in the next 12 months. This company generates high value from the labor resources and other capital it has available, and while it has heavy Long-Term Debt to Equity, the majority of the metrics point to this investment being highly attractive.